170 related articles for article (PubMed ID: 35381066)
1. Longitudinal study of 2 patients with cyclic thrombocytopenia, STAT3 and MPL mutations.
Zhang H; Chien M; Hou Y; Shomali W; Brar RS; Ho C; Han P; Xu D; Zhang BM; Guo X; Tolentino LL; Wu NC; Tsai AG; Jin J; Witteles WH; Chen Z; Abidi P; Jangam D; Krieger MS; Craig M; Bussel JB; Gotlib JR; Zehnder JL
Blood Adv; 2023 Jan; 7(1):190-194. PubMed ID: 35381066
[TBL] [Abstract][Full Text] [Related]
2. The highs and lows of cyclic thrombocytopenia.
Zhang H; Villar-Prados A; Bussel JB; Zehnder JL
Br J Haematol; 2024 Jan; 204(1):56-67. PubMed ID: 38083878
[TBL] [Abstract][Full Text] [Related]
3. Efficiently Restored Thrombopoietin Production by Ashwell-Morell Receptor and IL-6R Induced Janus Kinase 2/Signal Transducer and Activator of Transcription Signaling Early After Partial Hepatectomy.
Reusswig F; Fazel Modares N; Brechtenkamp M; Wienands L; Krüger I; Behnke K; Lee-Sundlov MM; Herebian D; Scheller J; Hoffmeister KM; Häussinger D; Elvers M
Hepatology; 2021 Jul; 74(1):411-427. PubMed ID: 33369745
[TBL] [Abstract][Full Text] [Related]
4. c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia.
Ballmaier M; Germeshausen M; Schulze H; Cherkaoui K; Lang S; Gaudig A; Krukemeier S; Eilers M; Strauss G; Welte K
Blood; 2001 Jan; 97(1):139-46. PubMed ID: 11133753
[TBL] [Abstract][Full Text] [Related]
5. Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation.
Heller PG; Glembotsky AC; Gandhi MJ; Cummings CL; Pirola CJ; Marta RF; Kornblihtt LI; Drachman JG; Molinas FC
Blood; 2005 Jun; 105(12):4664-70. PubMed ID: 15741216
[TBL] [Abstract][Full Text] [Related]
6. Screening for MPL mutations in essential thrombocythemia and primary myelofibrosis: normal Mpl expression and absence of constitutive STAT3 and STAT5 activation in MPLW515L-positive platelets.
Glembotsky AC; Korin L; Lev PR; Chazarreta CD; Marta RF; Molinas FC; Heller PG
Eur J Haematol; 2010 May; 84(5):398-405. PubMed ID: 20113333
[TBL] [Abstract][Full Text] [Related]
7. MPL expression on AML blasts predicts peripheral blood neutropenia and thrombocytopenia.
Rauch PJ; Ellegast JM; Widmer CC; Fritsch K; Goede JS; Valk PJ; Löwenberg B; Takizawa H; Manz MG
Blood; 2016 Nov; 128(18):2253-2257. PubMed ID: 27574191
[TBL] [Abstract][Full Text] [Related]
8. How I manage cyclic thrombocytopenia.
Kyrle PA; Eichinger S
Blood; 2021 Jan; 137(2):178-184. PubMed ID: 33197928
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin is a major regulator of thrombopoiesis in thrombopoietin-dependent and -independent contexts.
Hacein-Bey-Abina S; Estienne M; Bessoles S; Echchakir H; Pederzoli-Ribeil M; Chiron A; Aldaz-Carroll L; Leducq V; Zhang Y; Souyri M; Louache F; Abina AM
Exp Hematol; 2020 Aug; 88():15-27. PubMed ID: 32721504
[TBL] [Abstract][Full Text] [Related]
10. An ENU-induced recessive mutation in Mpl leads to thrombocytopenia with overdominance.
Chan ER; Lavender H; Li G; Haviernik P; Bunting KD; Adams MD
Exp Hematol; 2009 Feb; 37(2):276-84. PubMed ID: 19059699
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization of c-Mpl ectodomain mutations that underlie congenital amegakaryocytic thrombocytopenia.
Varghese LN; Zhang JG; Young SN; Willson TA; Alexander WS; Nicola NA; Babon JJ; Murphy JM
Growth Factors; 2014 Feb; 32(1):18-26. PubMed ID: 24438083
[TBL] [Abstract][Full Text] [Related]
12. The biology of thrombopoietin and thrombopoietin receptor agonists.
Kuter DJ
Int J Hematol; 2013 Jul; 98(1):10-23. PubMed ID: 23821332
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of single amino-acid mutations in the thrombopoietin-receptor Mpl underlying congenital amegakaryocytic thrombocytopenia.
Tijssen MR; di Summa F; van den Oudenrijn S; Zwaginga JJ; van der Schoot CE; Voermans C; de Haas M
Br J Haematol; 2008 Jun; 141(6):808-13. PubMed ID: 18422784
[TBL] [Abstract][Full Text] [Related]
14. Genetic Alterations of the Thrombopoietin/MPL/JAK2 Axis Impacting Megakaryopoiesis.
Plo I; Bellanné-Chantelot C; Mosca M; Mazzi S; Marty C; Vainchenker W
Front Endocrinol (Lausanne); 2017; 8():234. PubMed ID: 28955303
[TBL] [Abstract][Full Text] [Related]
15. Humanized VB22B minibody for human Mpl stimulates human megakaryopoiesis but does not enhance platelet aggregation.
Matsuki E; Miyakawa Y; Yamane A; Okamoto S
Exp Hematol; 2011 Aug; 39(8):829-36. PubMed ID: 21605620
[TBL] [Abstract][Full Text] [Related]
16. Defective response to thrombopoietin and impaired expression of c-mpl mRNA of bone marrow cells in congenital amegakaryocytic thrombocytopenia.
Muraoka K; Ishii E; Tsuji K; Yamamoto S; Yamaguchi H; Hara T; Koga H; Nakahata T; Miyazaki S
Br J Haematol; 1997 Feb; 96(2):287-92. PubMed ID: 9029014
[TBL] [Abstract][Full Text] [Related]
17. Thrombocytopenia in c-mpl-deficient mice.
Gurney AL; Carver-Moore K; de Sauvage FJ; Moore MW
Science; 1994 Sep; 265(5177):1445-7. PubMed ID: 8073287
[TBL] [Abstract][Full Text] [Related]
18. Hereditary thrombocytopenia due to reduced platelet production--report on two families and mutational screening of the thrombopoietin receptor gene (c-mpl).
Tonelli R; Strippoli P; Grossi A; Savoia A; Iolascon A; Savino M; Teriaca MS; Servedio V; Morfini M; Zelante L; Borgna-Pignatti C; Rosito P; Pession A; Paolucci G; Bagnara GP
Thromb Haemost; 2000 Jun; 83(6):931-6. PubMed ID: 10896251
[TBL] [Abstract][Full Text] [Related]
19. Functional roles of thrombopoietin-c-mpl system in essential thrombocythemia.
Matsumura I; Horikawa Y; Kanakura Y
Leuk Lymphoma; 1999 Jan; 32(3-4):351-8. PubMed ID: 10037033
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo expansion of human hematopoietic stem cells by a small-molecule agonist of c-MPL.
Nishino T; Miyaji K; Ishiwata N; Arai K; Yui M; Asai Y; Nakauchi H; Iwama A
Exp Hematol; 2009 Nov; 37(11):1364-1377.e4. PubMed ID: 19744539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
